Viracta Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Viracta Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Viracta Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$10.2M, a 18.4% increase year-over-year.
  • Viracta Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$47.2M, a 3.07% increase year-over-year.
  • Viracta Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$50.7M, a 0.21% decline from 2022.
  • Viracta Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$50.6M, a 55.7% increase from 2021.
  • Viracta Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$114M, a 507% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$47.2M -$10.2M +$2.29M +18.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$49.5M -$9.59M +$2.86M +23% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$52.4M -$13.9M -$1.67M -13.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$50.7M -$13.6M -$1.99M -17.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 -$48.7M -$12.5M +$5.6M +31% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$54.3M -$12.5M -$1.95M -18.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$52.4M -$12.2M -$1.78M -17% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$50.6M -$11.6M -$256K -2.26% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$50.3M -$18.1M -$3.28M -22.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$47.1M -$10.5M -$1.19M -12.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$45.9M -$10.4M +$68.4M +86.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$114M -$11.3M -$5.19M -84.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 -$109M -$14.8M -$10.8M -271% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$98.3M -$9.32M -$5.08M -120% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$93.2M -$78.8M -$74.4M -1669% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$18.8M -$6.13M -$772K -14.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$18M -$3.99M +$2.05M +33.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$20.1M -$4.24M +$1.97M +31.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$22.1M -$4.46M +$1.23M +21.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$23.3M -$5.35M +$406K +7.05% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-24
Q3 2019 -$23.7M -$6.04M +$236K +3.76% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$23.9M -$6.21M +$376K +5.71% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 -$24.3M -$5.69M +$1.4M +19.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$25.7M -$5.76M +$674K +10.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 -$26.4M -$6.28M +$3.66M +36.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$30M -$6.58M +$2.03M +23.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$32.1M -$7.09M +$2.34M +24.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$34.4M -$6.43M +$1.64M +20.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$36.1M -$9.94M -$1.41M -16.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 -$34.7M -$8.61M +$1.38M +13.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$36M -$9.44M +$429K +4.35% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$36.5M -$8.07M +$3.27M +28.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-09
Q3 2016 -$39.7M -$8.53M +$40K +0.47% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 -$39.8M -$9.99M +$630K +5.93% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-27
Q1 2016 -$40.4M -$9.86M -$1.1M -12.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 -$39.3M -$11.3M -$186K -1.67% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-09
Q3 2015 -$39.1M -$8.57M +$4.74M +35.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 -$43.9M -$10.6M +$981K +8.45% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-29
Q1 2015 -$44.8M -$8.77M +$205K +2.28% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$45M -$11.2M -$3.56M -46.9% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-09
Q3 2014 -$41.5M -$13.3M -$5.54M -71.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$35.9M -$11.6M -$3.03M -35.3% Mar 31, 2014 Jun 30, 2014 10-Q 2015-07-30
Q1 2014 -$32.9M -$8.97M -$1.14M -14.6% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 -$31.8M -$7.59M +$481K +5.96% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-14
Q3 2013 -$32.3M -$7.78M +$1.17M +13.1% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$33.4M -$8.57M +$180K +2.06% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 -$33.6M -$7.83M +$1M +11.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 -$34.6M -$8.07M +$412K +4.86% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 -$35M -$8.94M -$1.57M -21.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$33.4M -$8.75M -$829K -10.5% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-02
Q1 2012 -$32.6M -$8.84M -$6.75M -324% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$25.9M -$8.49M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-06
Q3 2011 -$7.37M -$2.09M -39.5% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 -$7.93M -$3.11M -64.5% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$2.08M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$5.28M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$4.82M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.